Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate the efficacy and safety of metronomic vinorelbine and bevacizumab
combination in patients with pretreated, advanced non small cell lung cancer